Fair Value Calculator Fair Value Calculator
EN DE

REMLIFE (REMLIFE) Fair Value & Analysis

IN · Market cap ₹750M

R REMLIFE REMLIFE · BSE
Price₹0.3200
Fair Value₹0.1500
Upside-53.1%
Quality27/100
Watch REMLIFE for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹0.1200 – ₹0.1900

Fair value as of: Jul 6, 2026

From 14 valuation models · updated today

Share price −8.6% over the past month.

Price vs Fair Value (12 months)

₹1.59 ₹0.2600 Fair Value ₹0.1500 Jun 2025 Jul 2026

12‑month range ₹0.2600 – ₹1.59 · fair‑value band ₹0.1200 – ₹0.1900 · the ₹0.3200 price screens above the ₹0.1500 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

REMLIFE (REMLIFE) currently trades at ₹0.3200, while our model-based Fair Value estimate is ₹0.1500 — implying the stock looks roughly 53.1% overvalued today. We read business quality at 27/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, REMLIFE generated revenue of ₹5.3B at a net margin of 2.3%. It earns a return on equity of 16.2%. Net debt stands at ₹447M. The stock trades on a trailing P/E of 6.5. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹0.1200 (bear case) to ₹0.1900 (bull case); at ₹0.3200, the current price sits above that range.

Key figures & financial health

Revenue (TTM) ₹5.3B
Revenue growth (YoY) +343%
Net margin 2.3%
Return on equity 16.2%
Free cash flow −₹11.4B FY2025
P/E ratio 6.5
More key figures
Operating margin 6.6%
EPS (TTM) ₹0.1300
EPS growth (YoY) +144%
Net debt ₹447M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

REMLIFE reported revenue of ₹4.1B in FY2025 versus ₹900M in FY2021, a compound +45.7%/yr. Reported net income was ₹21.3M in FY2025, compounding +45.1%/yr from FY2021.

Revenue +45.7%/yr
FY21 ₹900M
FY22 ₹5.0B
FY23 ₹5.1B
FY24 ₹40.4B
FY25 ₹4.1B
Net income +45.1%/yr
FY21 ₹4.8M
FY22 ₹10.8M
FY23 ₹54.3M
FY24 ₹327M
FY25 ₹21.3M

Is REMLIFE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "REMLIFE Fair Value". https://www.fairvalue-calculator.com/stock/REMLIFE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is REMLIFE (REMLIFE) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹0.1500 versus a price of ₹0.3200 — about −53% (overvalued). Model-based estimate, not financial advice.
What is the fair value of REMLIFE?
Our model-based fair value for REMLIFE is ₹0.1500 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹0.3200.
What is the quality score of REMLIFE?
REMLIFE has a Quality Score of 27/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of REMLIFE (REMLIFE)?
REMLIFE reported trailing-twelve-month revenue of about ₹5.3B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of REMLIFE?
The net profit margin of REMLIFE is about 2.3%, meaning it keeps roughly 2.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.